228 related articles for article (PubMed ID: 22200414)
1. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
[TBL] [Abstract][Full Text] [Related]
2. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis.
Sukumaran V; Veeraveedu PT; Gurusamy N; Yamaguchi K; Lakshmanan AP; Ma M; Suzuki K; Kodama M; Watanabe K
Int J Biol Sci; 2011; 7(8):1077-92. PubMed ID: 21927577
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
Sukumaran V; Watanabe K; Veeraveedu PT; Gurusamy N; Ma M; Thandavarayan RA; Lakshmanan AP; Yamaguchi K; Suzuki K; Kodama M
Int J Biol Sci; 2011 Feb; 7(2):154-67. PubMed ID: 21383952
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Life Sci; 2012 Feb; 90(7-8):289-300. PubMed ID: 22210452
[TBL] [Abstract][Full Text] [Related]
6. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
Yuan Z; Nimata M; Okabe TA; Shioji K; Hasegawa K; Kita T; Kishimoto C
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1147-52. PubMed ID: 15879491
[TBL] [Abstract][Full Text] [Related]
7. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
[TBL] [Abstract][Full Text] [Related]
8. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Arumugam S; Thandavarayan RA; Palaniyandi SS; Giridharan VV; Arozal W; Sari FR; Soetikno V; Harima M; Suzuki K; Kodama M; Watanabe K
Toxicology; 2012 Jan; 291(1-3):139-45. PubMed ID: 22120037
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
12. Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice.
Lakshmanan AP; Thandavarayan RA; Palaniyandi SS; Sari FR; Meilei H; Giridharan VV; Soetikno V; Suzuki K; Kodama M; Watanabe K
Eur J Pharm Sci; 2011 Dec; 44(5):627-34. PubMed ID: 22033153
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress.
Sukumaran V; Watanabe K; Veeraveedu PT; Ma M; Gurusamy N; Rajavel V; Suzuki K; Yamaguchi K; Kodama M; Aizawa Y
Eur J Pharmacol; 2011 Feb; 652(1-3):126-35. PubMed ID: 21115000
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
[TBL] [Abstract][Full Text] [Related]
15. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
Varagic J; Ahmad S; VonCannon JL; Moniwa N; Brosnihan KB; Wysocki J; Batlle D; Ferrario CM
Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
[TBL] [Abstract][Full Text] [Related]
16. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.
Nimata M; Kishimoto C; Yuan Z; Shioji K
Mol Cell Biochem; 2004 Apr; 259(1-2):217-22. PubMed ID: 15124927
[TBL] [Abstract][Full Text] [Related]
18. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
[TBL] [Abstract][Full Text] [Related]
20. Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling.
Arumugam S; Thandavarayan RA; Arozal W; Sari FR; Giridharan VV; Soetikno V; Palaniyandi SS; Harima M; Suzuki K; Nagata M; Tagaki R; Kodama M; Watanabe K
Free Radic Res; 2012 Feb; 46(2):154-63. PubMed ID: 22145946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
